Page 642 - Concise Pathology for Exam Preparation ( PDFDrive )
P. 642
Index 627
Frame shift mutations, 190 Hematopoietic cells, 112 Hyperplastic polyps, 412
Free radicals, 11 Hematopoietic system, 285 Hypersensitivity pneumonitis, 373
Fulminant hepatic failure, 432 Hemochromatosis, 27, 436–437 Hypersensitivity, 93t
Functions of liver, 421 Hemolytic anemia, 303 Arthus reaction, 100
extrinsic/extracorpuscular type, I, 97–98
abnormalities, 303t type II, 99–100
G intrinsic/intracorpuscular type III, 100–101
G6PD (glucose-6-phosphate abnormalities, 303t type IV, 102–103
dehydrogenase) enzyme, 306–307 Hemophilia, 348–349 Hypersplenism, 345
Galactosemia, 202 Hemosiderin, 26–27 Hypertension, 245–250
Gallstones, 445–448 Hemostasis, 345–347 benign hypertension, 245
Gangrene, 13, 14, 17 common pathway, 347f benign nephrosclerosis, 249
Gangrenous necrosis, 14 extrinsic pathway, 346f essential (primary) hypertension, 246
Gastric carcinoma, 401–403 intrinsic pathway, 346f malignant hypertension, 245
Gastritis, 396 Hemozoin, 27 malignant nephrosclerosis, 249–250
Gastrointestinal stromal tumour, 403 Hepatocyte growth factor/scatter secondary hypertension, 246
Gastroesophageal reflux disease, 393 factor, 57t Hyperthyroidism, 535
Genetic heterogeneity, 191 Hepatitis Hypertrophic osteoarthropathy, 146
Germ cell tumours, 491 HAV, 426 Hypertrophy, 5–6
Gestational trophoblastic disease, HBV, 426 Hypochromic anemias, 293
519–520 HCV, 428 Hypoparathyroidism, 551–552
choriocarcinoma, 521t Chronic, 430
H. mole, 521t HDV, 428
Ghon focus, 158, 160 HEV, 428 I
Giant cells, 52 Hepatoma, 443–444 Idiopathic thrombocytopenic purpura,
Gilbert syndrome, 425 Hepatoma/Hepatocellular carcinoma, 347–348
Glial fibrillary acidic protein, 148 443 IgA nephropathy (Berger’s disease), 474
Glioblastoma multiforme, 620 Hereditary coagulation disorders, 348 Immature teratoma, 494
Glitter cells, 614 Hereditary spherocytosis, 305–306 Immunity, 89
Glomerular syndromes, 463 Herpes simplex infection, 172–173 Immunohistochemistry, 147
Glycogenoses, 197, 205t Hexosaminidase, 203 Immunologic tolerance, 105–106
Glycosuria, 460 Heyman antigen, 464 Infarct, 83
Glycosyl-phosphatidylinositol (GPI) HIV-associated nephropathy, 472 red, 83
protein, 313 High-density lipoprotein, 114, 212, 241 renal, 84
Good Pasture syndrome, 108, 229, High molecular weight kininogen, 2 white, 83
464, 466, 467 HLA complex, 94f Infectious mononucleosis, 170–171
Goiter, 541–543 Hodgkin’s lymphoma (HL), 332–334 Inferior vena caval syndrome, 236
Gorlin syndrome, 140, 609 Reed’Sternberg (RS) cells, 332–333 Inflammation, 31
Gouty arthritis, 598–599 Homans sign, 236 acute, 34–35
Gram-negative bacteria, 35, 85, 154, Homeostasis, 2 cardinal signs, 31
155, 175 Horner syndrome, 382 chronic, 47
Gram-positive bacteria, 151 Homer–Wright rosettes, 586 Inflammatory bowel disease, 407–408
Granuloma pyogenic, 251 Homocystinuria, 202 Crohn’s disease, 408–409
Granulosa cell tumour of ovary, 512 Howell’Jolly bodies, 288–290t ulcerative colitis, 409
Granulation tissue, 52 HPV, 144 Inflammatory polyps, 411
Granulocytopenia, 315 Human chorionic gonadotrophins, 491 Inhibitors of angiogenesis, 141
Granulomatous inflammation, 50–51 Humoral immunity, 90 Innate immunity, 91
Graves, disease, 535–537 Humoral rejection, 112 Insudation hypothesis, 242
Gray (Gy), 215 Hurthle cell, 544 Insulin, 558
Growth factors (GFs), 57 Hutchinson’s teeth, 168 Interferons, 57t
Gumma, 51 Hyaline change, 24 Interleukins, 57t
GVHD, 113 Hydatidiform mole, 519 Intermediate filament, 437
Gynaecomastia, 533 Complete, 520 Intestinal tuberculosis, 406
Partial, 520 Intratubular germ cell neoplasi
Hydronephrosis, 488 (ITGCN), 491
H Hydroperoxyeicosatetranoic acid, 40 Intravascular hemolysis, 304
Hairy cell leukemia, 342–343 Hydropic/vacuolar degeneration, 22 Intrinsic asthma, 366
Hamartoma, 124 Hydrostatic pressure, 69 Inversion, 192
Hansen disease, 161 Hyperaldosteronism, 553–554 Involucrum, 572
Hamartomatous polyps, 411–412 primary, 553 Ionizing radiation, 215–216
Healing by primary or first secondary, 553 chronic effects of radiation, 216
intention, 62 Hyperemia, 72 Hazards of radiation, 215
Healing by secondary intention, 64 Hyperbilirubinaemia, 421, 425 Iron-deficiency anemia, 295
Heart failure, 281–284 Hyperlipidemia, 241 Iron metabolism, 290–292
Heart failure cells or siderophages, 74 Hyperparathyroidism, 549 Ischemic heart disease, 256
Heat shock proteins, 30 primary hyperparathyroidism, 549
Heberden’s nodes, 594 secondary hyperparathyroidism, 551
Heinz’s bodies, 288–290t tertiary hyperparathyroidism, 551 J
Helicobacter pylori, 145 water clear cells, 550 Jaundice, 423–425
Helper T cells, 95 Hyperplasia, 5 Juvenile polyps, 411
mebooksfree.com

